Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.505NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.505NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.74NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
B.1.1.74NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.1.74NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
B.1.406NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.406NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.406NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.115NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.115NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.115NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.29NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AA.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AA.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.133NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.133NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.133NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.466NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.466NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.466NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.489NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.489NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.489NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.363NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.363NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.363NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.95NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.95NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.95NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.26NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.26NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.531NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.531NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.531NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.45NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.45NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.200NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.200NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.200NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.299NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.299NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.299NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used